Annual Report 2020

3 The United Laboratories International Holdings Limited Annual Report 2020 July • The United Laboratories won the honor of “2019 China 100 Chemical Pharmaceutical Enterprises” by ranking the 18th. August • Zhuhai United Laboratories was awarded “2019 China Pharmaceutical Industry Top 100 Companies” (ranking the 21st) by China National Pharmaceutical Industry Information Center. • The United Laboratories was named “2020 Sina Finance Golden Kylin Most Valuable Hong Kong Stocks - Best IR Team”. • The United Laboratories was named “2019-2020 China Healthcare Enterprises of Best Investment Potential”. October • Zhuhai United Laboratories was awarded six honors by China Pharmaceutical Industry Association, including “2020 China Pharmaceutical Industry Top 100 Companies with Comprehensive Strength” and “2020 Leading Export Brand of Bulk Medicine of China’s Pharmaceutical Industry”. December • Mr. Tsoi Hoi Shan, Chairman of the Board, was named “Outstanding Innovative Entrepreneur” at the 3rd Zhongshan Non-Public Sector Phoenix Award. • The United Laboratories was named “10 Most Competitive Enterprises of National-level Foreign Trade Transformation and Upgrade Bases (Biopharmaceutics) of Zhuhai Jinwan District” and “2020 Special Contribution Award for Fighting COVID-19”. • The United Laboratories was named “Guangdong Private Enterprise of Outstanding Contribution in Fighting COVID-19”.